Drugs that contain Lenvatinib Mesylate
1. Drug name - LENVIMA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7253286 | EISAI INC | Nitrogen-containing aromatic derivatives |
Oct, 2025
(3 years from now) | |
| US7612208 | EISAI INC | Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
Sep, 2026
(3 years from now) | |
| US11186547 | EISAI INC | High-purity quinoline derivative and method for manufacturing same |
Aug, 2035
(12 years from now) | |
| US10407393 | EISAI INC | High-purity quinoline derivative and method for manufacturing same |
Aug, 2035
(12 years from now) | |
| US10259791 | EISAI INC | High-purity quinoline derivative and method for manufacturing same |
Aug, 2035
(12 years from now) | |
| CN101024627A | EISAI INC | Aromatic-Ring Derivative Including Nitrogen |
Nov, 2010
(11 years ago) | |
| CN101029022A | EISAI INC | Preparing Method Of Aromaticring Ramification Containing Nitrogen |
Oct, 2021
(11 months ago) | |
| CN1478078A | EISAI INC | Aromatic-Ring Derivative Including Nitrogen |
Oct, 2021
(11 months ago) | |
| CN1308310C | EISAI INC | Aromatic-Ring Derivative Including Nitrogen |
Oct, 2021
(11 months ago) | |
| CN101029022B | EISAI INC | Nitrogen-Containing Aromatic Ring Derivatives And Process For Their Preparation |
Oct, 2021
(11 months ago) | |
| CN101337931B | EISAI INC | Of Mesilate Of Acetic Acid Solvate Crystal (I) And Preparation Method Thereof |
Dec, 2024
(2 years from now) | |
| CN101337931A | EISAI INC | Mesilate And Acetic Acid To Object And Mesylate Is Crystal (I) And Its Preparation Method |
Dec, 2024
(2 years from now) | |
| CN101337933B | EISAI INC | Quinoline-Carboxamide Mesylate Crystal (A) And Its Preparation Method |
Dec, 2024
(2 years from now) | |
| CN101337933A | EISAI INC | Crystal (A) Of Mesilate Of Quinolinecarboxamide And Producing Method Thereof |
Dec, 2024
(2 years from now) | |
| CN100569753C | EISAI INC | 4 - (3 - (-4-(Cyclopropylaminocarbonyl) Aminophenoxy)--7 - Methoxy - -6 - Mesilate Of Crystal (C) And Preparation Method Thereof |
Dec, 2024
(2 years from now) | |
| CN101337932B | EISAI INC | Quinoline-Carboxamide Of Crystalline Form Of (B) And Its Preparation Method |
Dec, 2024
(2 years from now) | |
| CN1890220A | EISAI INC | A Crystalline Of The Salt Form Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Aminophenoxy)-7-Methoxy-6-Quinolinecarboxamide Or The Solvate Of The Salt And A Process For Preparing The Same |
Dec, 2024
(2 years from now) | |
| CN101337932A | EISAI INC | Crystal (B) Of Mesilate Of Quinolinecarboxamide And Producing Method Thereof |
Dec, 2024
(2 years from now) | |
| CN106660964A | EISAI INC | Quinoline Derivative With High Purity And Production Method Thereof |
Aug, 2035
(12 years from now) | |
| CN106660964B | EISAI INC | High Purity Quinoline Derivatives And Process For Producing The Same |
Aug, 2035
(12 years from now) | |
| IN236500B | EISAI INC | A Crystalline From Of The Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide |
Dec, 2024
(2 years from now) | |
| IN200602572P4 | EISAI INC | A Crystalline From Of The Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or The Solvate Of The Salt And A Process For Preparing The Same |
Dec, 2024
(2 years from now) | |
| EP1506962A2 | EISAI INC | Nitrogen-Containing Aromatic Heterocycles |
Oct, 2021
(11 months ago) | |
| EP1506962A3 | EISAI INC | Nitrogen-Containing Aromatic Heterocycles |
Oct, 2021
(11 months ago) | |
| EP1506962B1 | EISAI INC | Nitrogen-Containing Aromatic Heterocycles |
Oct, 2021
(11 months ago) | |
| EP1777218A1 | EISAI INC | Process For The Preparation Of 4-Phenoxy Quinoline Derivatives |
Oct, 2021
(11 months ago) | |
| EP1777218B1 | EISAI INC | Process For The Preparation Of 4-Phenoxy Quinoline Derivatives |
Oct, 2021
(11 months ago) | |
| EP1698623A1 | EISAI INC | Crystal Of Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or Of Solvate Thereof And Processes For Producing These |
Dec, 2024
(2 years from now) | |
| EP1698623B1 | EISAI INC | Crystal Of Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or Of Solvate Thereof And Processes For Producing These |
Dec, 2024
(2 years from now) | |
| EP1698623A4 | EISAI INC | Crystal Of Salt Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Amino-Phenoxy)-7-Methoxy-6-Quinolinecarboxamide Or Of Solvate Thereof And Processes For Producing These |
Dec, 2024
(2 years from now) | |
| EP1415987A4 | EISAI INC | Nitrogenous Aromatic Ring Compounds |
Oct, 2026
(4 years from now) | |
| EP1415987A1 | EISAI INC | Nitrogenous Aromatic Ring Compounds As Anti Cancer Agents |
Oct, 2026
(4 years from now) | |
| EP1415987B1 | EISAI INC | Nitrogenous Aromatic Ring Compounds As Anti Cancer Agents |
Oct, 2026
(4 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9006256 | EISAI INC | Antitumor agent for thyroid cancer |
Jul, 2027
(4 years from now) | |
Treatment: Method for treating thyroid carcinoma including differentiated thyroid cancer
Dosage: CAPSULE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 4MG BASE | CAPSULE;ORAL | Prescription |
| EQ 10MG BASE | CAPSULE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.